Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Nintena 150mg Tablets | 100-Count | NINTEDANIB
Pharma

Nintena 150mg Tablets | 100-Count | NINTEDANIB

$260

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse NINTEDANIB — 150mg per tablet, 100-count pack. Tyrosine kinase inhibitor antifibrotic for idiopathic pulmonary fibrosis (IPF), interstitial lung diseases associated with systemic sclerosis or RA, and second-line NSCLC. Key warning: Hepatotoxicity monitoring with LFTs. Diarrhea management crucial (loperamide, fluid replacement). Embryofetal toxicity. Cardiovascular risk (arterial thromboembolic events). Avoid in severe hepatic impairment.

SKU
VES-007252-NINTENA-150MG-100TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Nintena 150mg (NINTEDANIB)?

Tyrosine kinase inhibitor antifibrotic for idiopathic pulmonary fibrosis (IPF), interstitial lung diseases associated with systemic sclerosis or RA, and second-line NSCLC.

How it Works

Inhibits VEGFR, FGFR, and PDGFRalpha — blocks pro-fibrotic and angiogenic signaling pathways. Reduces fibroblast proliferation, differentiation, and migration in the lung.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
NINTEDANIB
Dose per Tablet
150MG
Pack Size
10×10 (100 tablets)
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Diarrhea (very common — 60%+ of patients), nausea, abdominal pain, elevated liver enzymes, weight loss.

Safety Warnings

Hepatotoxicity monitoring with LFTs. Diarrhea management crucial (loperamide, fluid replacement). Embryofetal toxicity. Cardiovascular risk (arterial thromboembolic events). Avoid in severe hepatic impairment. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.